Note: Ingredients listed on restricted chemical lists
General Information
Product name
Bosentan Tablets for Oral suspension 32 mg
1.2.1 Relevant identified uses
Finished Pharmaceutical Product This SDS is only intended for occupational use
supplier name
Natco Pharma Limited
Icons in SDS
Company Information
company name
Natco Pharma Limited
GHS Information
Signal word
I
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Medicinal products in the finished state, intended for the fmal user, are not subject to GHS labelling.
Signal word
I Warning H317 May cause an allergic skin reaction. H319 Causes serious
Hazard statements
eye irritation. H361d Suspected of damaging the unborn child. ±
Precautionary statements
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. NATCO PHARMA LIMITED - VISAKHAPATNAM SAFETYDATA SHEET Product Name - Bosentan Tablets for Oral suspension 32 mg P261 Avoid breathing dust! thme! gas! mist! vapours! spray. P264 Wash skin thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. - P280 Wear protective gloves! protective clotinng/ eye protection! face protection.
Response
P302 + P352 IF ON SKiN: Wash with plenty of soap and water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or. concerned: Get medical advice! aft ention. P333 + P313 If skin irritation or rash occurs: Get medical advice! attention. P337 + P313 If eye irritation persists: Get medical advice! attention. _____________________________ P363 Wash contaminated clothing before reuse. -
Storage
P405 Store locked up.
Disposal
P501 Dispose Of thntents! dbfflalne to anipproved Waste - disposal plant. _______________________________ -
2.3 Other hazards
None known
